Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 16/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22462062 | 0.86 | PDK2 (0.43) | PDK2APEX1KDM4E | |
| SCHEMBL23805933 | 0.84 | PDK2 (0.44) | PDK2APEX1 | |
| SCHEMBL16550638 | 0.82 | PDK2 (0.53) | PDK2APEX1 | |
| SCHEMBL4822886 | 0.81 | PDK2 (0.43) | PDK2APEX1 | |
| SCHEMBL18235863 | 0.81 | PDK2 (0.45) | PDK2APEX1 | |
| SCHEMBL23805907 | 0.80 | APEX1 (0.47) | PDK2APEX1 | |
| SCHEMBL14768863 | 0.79 | PDK2 (0.45) | PDK2APEX1 | |
| SCHEMBL21025023 | 0.78 | PDK2 (0.45) | PDK2APEX1 | |
| SCHEMBL22462068 | 0.78 | PDK2 (0.45) | PDK2APEX1 | |
| SCHEMBL25070269 | 0.78 | APEX1 (0.47) | PDK2APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | TRPA1, TYR, PKLR | PDK2 58/4885APEX1 3229/4885KDM4E 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.